ProShares Ultra NASDAQ Biotechnology
27 hedge funds and large institutions have $15.6M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
7
Closed
5
Calls
$8.63M
Puts
$12.5M
Net Calls
-$3.86M
Net Calls Change
-$5.56M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Koshinski Asset Management
Decatur,
Illinois
| $254 | 4,587 | +4,587 | New |
|
|
VF
27
Virtu Financial
New York
| – | – | -36,142 | Closed |
|
28
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | – | -1,000 | Closed |
|
29
UBS Group
Zurich,
Switzerland
| – | – | -642 | Closed |
|
|
CG
30
Cutler Group
San Francisco,
California
| – | – | -399 | Closed |
|
|
IA
31
IFP Advisors
Tampa,
Florida
| – | – | -175 | Closed |
|
32
Parallax Volatility Advisers
San Francisco,
California
| $0 | 2 | – | – |
|
33
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
34
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
PFC
35
Phocas Financial Corp
Alameda,
California
| – | – | – | – |
|